NDC 62856-535

BELVIQ XR

Lorcaserin Hydrochloride Hemihydrate

BELVIQ XR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Lorcaserin Hydrochloride Hemihydrate.

Product ID62856-535_3097271d-6dae-4dce-91c2-783e31678eb6
NDC62856-535
Product TypeHuman Prescription Drug
Proprietary NameBELVIQ XR
Generic NameLorcaserin Hydrochloride Hemihydrate
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2016-07-15
Marketing CategoryNDA / NDA
Application NumberNDA208524
Labeler NameEisai Inc.
Substance NameLORCASERIN HYDROCHLORIDE HEMIHYDRATE
Active Ingredient Strength20 mg/1
Pharm ClassesSerotonin-2c Receptor Agonist [EPC],Serotonin 2c Receptor Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA]
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 62856-535-30

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62856-535-30)
Marketing Start Date2016-07-15
Marketing End Date2022-05-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62856-535-30 [62856053530]

BELVIQ XR TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA208524
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-07-15

Drug Details

Active Ingredients

IngredientStrength
LORCASERIN HYDROCHLORIDE HEMIHYDRATE20 mg/1

OpenFDA Data

SPL SET ID:7cbbb12f-760d-487d-b789-ae2d52a3e01f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1300712
  • 1808552
  • 1808549
  • 1300706
  • UPC Code
  • 0362856529600
  • 0362856535304
  • Pharmacological Class

    • Serotonin-2c Receptor Agonist [EPC]
    • Serotonin 2c Receptor Agonists [MoA]
    • Cytochrome P450 2D6 Inhibitors [MoA]

    Medicade Reported Pricing

    62856053530 BELVIQ XR 20 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "BELVIQ XR" or generic name "Lorcaserin Hydrochloride Hemihydrate"

    NDCBrand NameGeneric Name
    62856-535BELVIQ XRlorcaserin hydrochloride hemihydrate
    62856-529Belviqlorcaserin hydrochloride hemihydrate

    Trademark Results [BELVIQ XR]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    BELVIQ XR
    BELVIQ XR
    86693918 4908131 Live/Registered
    EISAI INC.
    2015-07-15
    BELVIQ XR
    BELVIQ XR
    86693911 4922297 Live/Registered
    Arena Pharmaceuticals GmbH
    2015-07-15
    BELVIQ XR
    BELVIQ XR
    86330779 4695303 Live/Registered
    EISAI INC.
    2014-07-08

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.